Ferritins managing iron-oxygen biochemistry in animals, plants, and microorganisms belong to the diiron carboxylate protein family and concentrate iron as ferric oxide Ϸ10 14 times above the ferric Ks. Ferritin iron (up to 4,500 atoms), used for iron cofactors and heme, or to trap DNA-damaging oxidants in microorganisms, is concentrated in the protein nanocage cavity (5-8 nm) formed during assembly of polypeptide subunits, 24 in maxiferritins and 12 in miniferritins͞DNA protection during starvation proteins. 
I
ron and oxygen are integral to life, but their chemistry requires many proteins with iron cofactors to harness them for respiration, photosynthesis, and DNA synthesis, while minimizing radical side reactions. Ferritins, cage-like nanoproteins, concentrate iron for cofactor synthesis, as a mineral (hydrated ferric oxide), in large, central cavities (5-8 nm) . Ferritin nanocavities form during the spontaneous assembly of ellipsoidal, polypeptide subunits (1-3), 24 in maxiferritins (Ϸ480 kDa) and 12 in miniferritins (240 kDa), also called DNA protection during starvation proteins. The biological importance of ferritin is emphasized by the lethality of ferritin gene deletion in mammals (4) , defects in the CNS from mutations in humans (5) , and oxidant sensitivity after deletions of the multiple ferritins in bacteria (6) (7) (8) . Reactions of iron and oxygen catalyzed by maxiferritins, in cells of higher plants, animals including humans, and microorganisms, stabilize iron with oxygen at 10 14 times above the K s to match cellular iron concentrations, whereas miniferritins protect DNA by trapping oxidants with iron in the hydrated ferric oxide mineral.
Catalytic ferroxidase (F ox ) sites in ferritin catalyze the first in the series of reactions converting soluble ferrous ions to solid, concentrated ferric biomineral inside ferritin. The location of F ox sites in ferritin has been inferred to be in the center of each active subunit for maxiferritins and at junctions of subunit dimers in miniferritins, based on models of protein cocrystals with Fe 2ϩ analogues such as Mg 2ϩ or Ca 2ϩ (7) (8) (9) (10) (11) (12) (13) . Such models are reasonable for the ferrous substrate, but not for ferric intermediates such as the diferric peroxo (DFP) complex or products such as diferric oxo͞hydroxo mineral precursors. There are at least four types of metal-protein sites in ferritin (iron entry, exit, nucleation, and F ox substrate). Thus, a number of assumptions are required if a crystal-metal site is assigned to one of the multiple, iron-dependent ferritin functions. Even when two Mg 2ϩ or two Ca 2ϩ ions are relatively near each other in ferritin cocrystals, the metal-metal distances in the models were much longer than the Fe 3ϩ -Fe 3ϩ distance in the functional DFP intermediate, determined by extended x-ray absorption fine structure analysis in solution (11, 12, 14) . F ox site models have also relied on analogies to iron sites of other diiron carboxylate family members that form DFP intermediates (15) (16) (17) , even when iron is a cofactor and contrasts with ferritin F ox sites where iron is a substrate. Direct functional and structural studies of ferritin F ox sites in solution are needed.
Chimeric proteins, in which guest active sites are introduced into a host protein, have been used to understand structurefunction relationships in a variety of proteins such as globin, amyloid aggregates, angiotensin, and thrombin (18) (19) (20) . The results of characterizing ferritin F ox guest site activity in chimeric proteins shown here reveal that ferritin DFP formation required more iron ligands than ferrous oxidation. DFP formation in ferritin depended on coupling iron atoms in two iron substrate sites, E, EXXH for site A and E, QXXD for site B, that contrast with diiron cofactor sites where A and B are both E, EXXH and iron remains bound to the protein (21) (22) (23) (24) (25) (26) . The difference in site B and similarity in site A between diiron cofactor and diiron substrate sites among members of the diiron carboxylate family and the weaker ligand set in site B of the ferritin iron substrate site indicate that the B site determines whether the metalprotein interaction is very stable (diiron cofactor) or transient (diiron substrate).
Experimental Methods Protein Engineering and Expression.
A natural, catalytically inactive ferritin protein sequence, the animal-specific L ferritin, was selected as the host in which the chimeric oxidation site was designed because the quaternary structures of ferritin of both catalytically active (H-subunit recombinant ferritin) and catalytically inactive (L-subunit recombinant ferritin) forms are very similar (10 -13, 27) . Recombinant L frog ferritin was used as the model ferritin because the kinetic properties of frog ferritins have been particularly favorable for spectroscopic and mechanistic studies (3, 14, 16, (27) (28) (29) (30) . Frog and human ferritins are very similar both structurally (10, 11) and mechanistically (14, 28, 31) . However, an early attempt to construct a catalytically active site in human L ferritin led to insoluble protein that had weak mineralization activity when analyzed after solubilization and folding with guanidine in the presence of catalytically active H-ferritin subunits. Whether the solubilized chimeric protein catalyzed the formation of the DFP complex was not examined (32) .
QuikChange mutagenesis kits (Stratagene) were used for site-directed mutagenesis in pET-3a with expression in Escherichia coli BL21 (DE3)-pLysS as described in refs. 27, 29, 30, 33, and 34. The entire coding region was analyzed to verify sequence retention. Primers were as follows: K23E: forward, 5Ј-CGGTGAATCTGGAGTTCCACAGCTC-3Ј; reverse, 5Ј-AGCTGTGGAACTCCAGATTCACCG-3Ј. Q103E: forward, 5Ј-GTTTACGGATTTCTCCAGCTTTAGAGC-3Ј; reverse, 5Ј-GCTCTAAAGCTGGAGAAATCCGTAAAC-3Ј. S137Q: forward, 5Ј-GTCGGAGCAGGTAGAGAC-3Ј; reverse, 5Ј-GTCTCTACCTGCTCCTAC-3Ј. T140D: forward, 5Ј-GAGAGCGTAGAGGACATTAAGAAACTTG-3Ј; reverse, 5Ј-CAAGTTTCTTAATGTCCTCTACGCTCTC-3Ј.
Protein expression of WT and chimeric ferritin proteins in E. coli used methods described in refs. 27, 29, 30, 33 , and 34 and included growth for 6 h at 30°C in LB medium with inducer, followed by sonication in 20 mM Bis-Tris-propane (pH 7.5), heat coagulation of soluble, nonferritin proteins (10 min at 65°C), concentration with 45% saturated ammonium sulfate, purification using mono-Q (Pharmacia) FPLC (linear NaCl gradient, 0-1 M), and dialysis against 100 mM Mops͞200 mM NaCl (pH 7.5). Endogenous iron, minimized by using acid-washed glassware, varied from 2 to 17 iron atoms per protein molecule (0.06-0.6 iron atom per subunit).
Kinetic Analysis of Oxidation and DFP Formation. Ferrous substrate (FeSO 4 in 1 mM HCl, 0.05-2 mM) was rapidly mixed with ferritin solutions (4.16 M ϭ 100 M in subunits in 200 mM Mops, pH ϭ 6, 7, or 8) in a stopped-flow UV-visible spectrophotometer (Applied Photophysics, Surrey, U.K.) to achieve molar ratios of ferrous ion to protein from 12 to 480 iron atoms per ferritin molecule (0.5-24 iron per subunit). Data were collected at 650 nm, the absorption maximum of DFP (28) value to the degrees of freedom in the model) set at Ͻ6. A simple model for cooperativity was chosen over models with increased degrees of freedom because the kinetic contributions of the many different types of iron-protein interactions in ferritin (3, 28, 35, 38) are incompletely understood. The k cat for DFP formation of different proteins was calculated from V max by using a molar extinction coefficient for DFP of 1,000 M Ϫ1 ⅐cm
Ϫ1
at 650 nm (28) . DFP half-life (s) was computed by using the first-order exponential curve to fit the decay part of each kinetic trace,
where the a is a constant, V i is the initial decay rate, t is the time, and C (t 1/2 ) ϭ 1 ⁄2 C 0 . When DFP formation was absent, rates of ferrous oxidation were measured at 350 nm at two ratios of iron to protein, 48 (2 per F ox site) and 480; the initial rate at saturating iron for the F ox site (480 per ferritin) was used as V max in calculating specific activities. All data presented were computed from measurements on two to five independent protein preparations, each analyzed two to eight times.
Results
Host-Guest Design Strategy. Direct identification of ferritin F ox site residues used guest F ox sites with putative active site residues introduced in a F ox -inactive, ferritin-L subunit. Putative F ox site ligands were the bimetallic Mg (11, 12) . L-ferritin subunits are animal specific and encoded in H-ferritin gene duplications, retaining the information for subunit helix bundles, the cavity, pores, and the ability to form mineral, albeit at very slow rates, but lacking active F ox sites (1) (2) (3) . In vivo, the F ox active and inactive subunits coassemble in tightly regulated, cell-specific ratios that affect the overall F ox activity of the ferritin protein. Among vertebrate L ferritins, frog L ferritin was chosen as the host because it conserves more of the putative F ox site amino acids ( Table 1) . The potential for fewer amino acid substitutions to create an active guest F ox site minimizes the possibility of insoluble protein, as encountered in an earlier experiment with human L ferritin (32) . In addition DFP has been mainly characterized in F ox active frog ferritins (14, 16, 28, 34, 39) , and both active and inactive frog ferritins have been crystallized (10, 12, 27) .
Based on the predicted F ox site residues from ferritin crystal structures with Mg 2ϩ and Ca 2ϩ , metal analogues for diiron substrate binding and analogies to the diiron cofactor sites of 
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methane monooxygenase and ribonucleotide reductase, residues that might inhibit iron substrate binding or alter F ox activity in the frog L-ferritin host, are K23 in the putative site A and Q103 and S137 in the putative site B. In other L ferritins, potential F ox -activity inhibitors include K58 and G61, which in frog L ferritin are E58 and H61, as in F ox active ferritins.
Introducing Putative A Site Residues of the Guest Diiron Fox Site in an L-Ferritin Host (L؉1).
The putative A site of the ferritin F ox site shares the E, EXXH motif with the diiron cofactor proteins. In the L host chosen, with E58 and H61 already present, only one substitution, K23E (Table 1) is required to complete the putative A site. Because the configuration of K23 in frog L-ferritin-Mg 2ϩ crystals is superimposable with that of E23 in the human H ferritin Ca 2ϩ cocrystal (10), replacement of the positive side chain with a negative side chain should be readily accommodated. Whereas the Lϩ1 protein is indeed a stable, expressible protein, the effect of completing the substrate A site had negligible effects on F ox activity. Ferrous oxidation increased minimally (3.3-fold), measured at 350 nm ( Fig. 1) , and no DFP (A at 650 nm) was detected. A group of potential iron ligands near the putative substrate B site that might have contributed to iron binding in Lϩ1 (10), such as Q103 and E136, apparently had little influence, because the Lϩ1 protein displayed a ferrous oxidation progress curve similar to the parent L protein (Fig. 1) . The ferrous oxidation rate in Lϩ1 with a completed A site was only 0.18% of F ox active ferritin (Table 2) , revealing specific contributions of the B site to F ox activity, and suggesting diiron cooperative binding as a prerequisite for activity in ferritin.
Constructing the Putative Substrate B Site in the Guest Fox Site of an L-Ferritin Host (L؉2, L؉3, and L؉4). To achieve F ox activity in the chimeras that was comparable with WT proteins for K app and the Hill coefficient (Tables 1 and 2 ), three substitutions were required in chimera Lϩ1 (with completed A site) to complete the B site. Single substitution of any of the amino acids, S137Q, Q103E, or T140D, had little effect on ferrous oxidation rates (Fig. 1) . The required substitutions at site B for DFP formation (A at 650 nm) in ferritin with a complete A site (E23, E58, and H61) were S137Q (Lϩ2), T140D (Lϩ3), and Q103E (Lϩ4).
The strategy for introducing the three B site substitutions required for DFP formation was to make the most nonconservative substitutions first, with the goal of gaining the maximum effect on activity with the minimum effect on expression of soluble, recombinant protein. S137Q (Lϩ2) was introduced first because Q137 is conserved not only at the protein level in all eukaryotic maxiferritins (Table 1) but even the DNA codon is conserved (E.T., unpublished results). D140 was introduced next, because D140 in frog M(HЈ) ferritin, also found in plant ferritin (40) , has more favorable F ox kinetic properties than frog H with S140, also found in mammalian mitochondrial ferritin (41) and a variety of cytoplasmic ferritins ( Table 1) .
Substitution of S137Q in Lϩ1 to make Lϩ2 increased the initial Fe 2ϩ oxidation rate 90-fold (Table 2) but with no detectable DFP activity (Fig. 1) . The absence of DFP formation coupled with an increased rate of ferrous oxidation (Fig. 1 ) suggests side reactions with ferric-oxy products off the DFP path to mineralization. When D140 was substituted for T in Lϩ2 to make Lϩ3, initial rates of ferrous oxidation reached WT levels (Table 2) , and DFP was detected at low levels. In Lϩ3 (Fig. 2) , ferrous oxidation rates were 580-fold higher than L or Lϩ1 and 6-fold higher than Lϩ2. Such results show that the minimum requirements for DFP formation are a fully functional A site (E23, E58, H61) plus a B site consisting of Q103, Q137, and D140.
Q103 in the frog L ferritin is different from the conserved residue E at position 103 in WT F ox active proteins, suggesting that a Q103E substitution might influence F ox kinetics in the chimera, even though Lϩ3 had WT ferrous oxidation rates ( Fig.  1 ) and detectable DFP formation (Fig. 2) . The importance of the carboxylate rather than the amide at position 103 in the B site is illustrated in the Lϩ4 chimera, where the rate of DFP formation was 123-fold higher than Lϩ3 (Table 2) , although there was little effect on the ferrous oxidation rate, which increased only 1.3-fold. The selective shift to the DFP reaction pathway in the Q103E substitution is likely due to increased stabilization of the DFP intermediate. (Table 1) and Mg 2ϩ or Ca 2ϩ ligands in ferritin crystals (11, 12) . ࡗ, H-WT A site: E23, E58, and H61; B site: E103, Q137, and S140. ‚, Lϩ3 A site: E23, E58, and H61; B site: Q103, Q137, and D140. s, M(HЈ)-WT A site: E23, E58, and H61; B site: E103, Q137, and D140. OE, Lϩ4 A site: E23, E58, and H61; B site: E103, Q137, and D140. ᮀ, Lϩ2 A site: E23, E58, and H61; B site: Q103, Q137, and T140. Lϩ1: E, L-K23E; ϩ, L-S137Q; Ϫ, Q103E; ⅙, L-T140D; and ϫ, S137Q͞T140D. F, L-WT (host). 
The Effect of Fox Site Structure and pH on Kinetic Properties of the DFP
Intermediate. Kinetic analysis of DFP formation and decay, difficult with many of the earlier fixed-time measurements (28, 31) , showed that in Lϩ4 adding E103 both accelerated the formation rate Ͼ100-fold, k cat (Q103) ϭ 0.27 and k cat (E103) ϭ 33 s Ϫ1 (Table 2) , and increased the cooperativity of the DFP formation reaction (Table 2 and Fig. 2 ). In Lϩ4, both K app and the Hill coefficient were close to WT values, although k cat was lower ( Table 2 ). The kinetic difference between the Lϩ4 chimera and WT M(HЈ) ferritin with the same F ox site ligands indicates contributions to the kinetics from residues beyond the F ox site affecting the DFP reaction pathway but not the lessspecific ferrous oxidation. A role for residue 140 in DFP kinetics was shown by comparing WT, F ox active isoforms where residue 140 is D, S, or A ( Table 2 ). Few differences were observed in kinetic comparisons of frog H ferritin (S140) and frog M(HЈ) ferritin (D140) for the ferrous oxidation rate, Hill constant, or K app , which is similar to the comparison of E103 and Q103 chimeras. DFP formation rates also varied similarly to Q103 substitutions, with S140 (H-ferritin) associated with a rate decrease in DFP formation of 67% ( Table 2 ). The D140 ferritin form predominates in liver, and the S140 form predominates in erythroid cells (42) .
Varying pH influenced ferrous oxidation and DFP formation kinetics selectively depending on the protein (Table 2) , showing protein-dependent effects on ferrous oxidation rates that are distinct from those of the inorganic, aqueous oxidation chemistry of ferrous ions. The pH effect was the largest between pH 6 and 7 (Fig. 3) , suggesting that factors influencing DFP kinetics are ionization of amino acid side chains such as histidine, with a normal pK a in the 6-7 range, or carboxylate with an unusual pK a in the pH 6-7 range, or hydrolysis of the DFP intermediate to form a -oxo͞hydroxo bridge that can also be in the pH 6-7 range. (43) . The difference in the effect of pH on Lϩ4 kinetics, where the initial DFP rates between pH 6 and 7 increased more than 123-fold compared with only 10-fold for WT M(HЈ), is dramatic (Fig. 3) . Because both proteins have the same F ox site, the differential effect of pH on F ox kinetics indicates that exogenous protons are less effective in regulating F ox kinetics than the WT, second-shell residues that are absent in the chimera.
DFP decay rates were also sensitive to changes in pH. In WT F ox -active ferritins, both DFP initial rates of formation (Table 2) and decay rates (Fig. 2) increased with increasing pH. However, the rate changes were roughly equivalent, and the t 1/2 did not change. For example, for M(HЈ) the t 1/2 was 0.089 Ϯ 0.007 s at pH 7 and 0.109 Ϯ 0.005 s at pH 8, whereas for H, t 1/2 was 0.417 Ϯ 0.029 s at pH 7 and 0.473 Ϯ 0.024 s at pH 8) (Fig. 3) . The cell-specific combinations of F ox -active and inactive ferritin subunits, which affect the rates of DFP formation, release of diferric oxy products (mineral precursors) and hydrogen peroxide (28, 31, 37, 39) , may be related to the specific ability of each cell type to manage hydrogen peroxide. In the chimera Lϩ4, pH had a much larger effect on DFP decay and half-life (Fig. 2) than on the WT protein (Fig. 3) . DFP did not decay in Lϩ4 until the pH was raised to pH 8. t 1/2 was greater than 100 s at pH 7 and 4.303 Ϯ 0.745 s at pH 8 ( Figs. 2 and 3) , indicating the absence of second-shell residues in the chimeras that influence substrate-product channeling.
Discussion
DFP intermediates in biological reactions of ferrous ions with oxygen are characteristic of both proteins where diiron cofactors react with dioxygen to oxidize organic substrates, and ferritins, where two ferrous ion substrates are coupled by using dioxygen to form diferric oxo͞hydroxo mineral precursors and hydrogen peroxide as the second product (14, 16, 28, 31, 39) . Coupling and oxidation of the two ferrous ions via oxo͞hydroxo bridges, the result of ferritin F ox activity, apparently overcomes diffusion limits on mineralization rates, and possibly activates protons, because the pK a of water coordinated to iron decreases from Ϸ9 for ferrous to as low as Ϸ3 for ferric. The stoichiometric formation of hydrogen peroxide (39) , which occurs during release of the diferric mineral precursors, may also be a biological signal (44) for changes in cellular iron. Identification of the F ox site in ferritin, impeded in the past by the transient nature of the substrate iron-F ox site interaction, relied on ferritin crystals with the Fe 2ϩ analogues Mg 2ϩ and Ca 2ϩ (11, 12) . Now, by introducing a set of putative F ox site residues, suggested by No DFP was detected in Lϩ4 at pH 6 and the value for pH 7͞6 was computed by using as the value for the minimum detectable rate, 0.27 ⌬A 650⅐s Ϫ1 per mg of protein.
dimagnesium sites in a ferritin-Mg 2ϩ cocrystal (12), both cumulatively and singly, into a F ox -inactive, L-ferritin host that already had the putative iron ligands E58 and H61, and by analyzing rapid DFP and oxidation kinetics (14, 16, 28, 31, 39) in each chimera (Figs. 2-4 and Table 2 ), we have directly identified the site required for F ox activity (Figs. 2-4 and Table  2 ) to include E23, E103, Q137, and D140.
Kinetic evidence that the residues for F ox activity have been identified are the comparable values for K app and the Hill coefficient in the DFP-formation reaction (Table 2) , in chimera Lϩ4 where the guest F ox site converted F ox -inactive L ferritin to a F ox -active H ferritin. The inactive and active ferritin proteins had the same subunit secondary structure, which assembled to form the large nanocavity and eight pores (10) , but the L-ferritin host lacked many of the putative iron-binding ligands that were suggested by dimetallic centers in ferritin crystals of the ferrous ion analogues, Ca 2ϩ and Mg 2ϩ (11, 12) . The dimetallic site in ferritin has the two subsites common to diiron carboxylate proteins, A and B. Completion of the putative A site in the chimera Lϩ1, by introducing E23, was ineffective in conferring F ox activity (Fig. 1) on the inactive host L ferritin. F ox activity required introduction, into Lϩ1, of two residues of the putative B site, Q137 and D140 (Lϩ3 chimera) (Figs. 2-4 and Table 1 ). Residue 103 was glutamine in the inactive L-ferritin host. When Q103 was converted to E103, the WT residue, F ox activity increased significantly ( Table 2) . The results are supported by earlier subtractive mutagenesis, where only ferrous oxidation was measured, and where the role of B site residues 103 and 140 could not be fully examined (35, 45, 46) . In cocrystals of F ox -active ferritin with Mg 2ϩ and Ca 2ϩ , E58 participates in both A and B sites, binding as a bidentate ligand (11, 12) . However, because the metal-to-metal distances in the crystals are about 1 Å longer than the diferric distance in DFP in solution (14) , the actual configuration of E58 is difficult to predict. Completion of the octahedral iron coordination of DFP and F ox products, observed by solution spectroscopy (14, 16, 28) , likely requires the ordered water observed in ferritin crystals (10) (11) (12) , which may be partly dissociated at different stages of the catalytic reaction. It is clear that further spectroscopic studies on engineered ferritins and chimeras will be needed to determine the F ox site geometry during catalysis, because the geometry of ferritin crystals with ferrous analogues does not match current spectroscopic information on iron-ferritin complexes.
When the ferritin F ox sites A and B for the iron substrate are compared with sites A and B in the diiron cofactor proteins (members of the same diiron carboxylate protein family as the ferritins), it is the A site that is common and the B site that varies. The weaker iron ligands Q and D in the ferritin F ox B substrate site, compared with stronger iron ligands E and H at analogous B sites in diiron cofactor proteins such as methane monooxygenase and ⌬ 9 -stearoyl fatty acid desaturase acyl carrier protein (21, 22) , explain release of the diferric oxo͞hydroxo products from the F ox site in ferritin and retention of the diferric cofactors in methane monooxygenase and ⌬
9
-stearoyl fatty acid desaturase acyl carrier protein. Apparently, the B site has the greater influence on the stability of the diiron-protein interaction during catalysis in ferritin. The codons for Q͞E and H͞D are related by single nucleotide differences, suggesting that evolution of protein cofactor sites from substrate sites or vice versa could be as simple as mutating single DNA nucleotides in two codons.
Contributions of ferritin second-shell residues to substrateproduct channeling were shown indirectly by the differences in k cat for DFP formation between chimera Lϩ4 and WT proteins (Figs. 1-3 and Table 2 ), where the A and B site residues are identical and K app values are similar. The lower k cat for Q103 (Lϩ3), compared with E103 (Lϩ4), may relate to second-shell interactions, to the different iron-protein interactions of the amide (Q) or carboxylate (E) amino acid side chains, or to both. Because DFP formation is the major route of iron biomineralization at physiological concentrations of oxygen (37), ferrous oxidation rates that are faster than the DFP formation rates, as in Lϩ3 for example (Table 2) , may represent side reactions that produce the monoferric species, observed after mutagenesis of DNA encoding residue E103 (35) . A possible second-shell residue is Y30, because it is hydrogen bonded to F ox residue E103 in Ca 2ϩ crystals of F ox -active ferritin (11) , and because the substitution F30Y inhibits F ox activity (e.g., ref. 34). F ox site variations in residue 140, D, S, or A, occur among the different natural isoforms that are differentially expressed in various cell types (41, 42) and coincide with different DFP kinetics. For example, the k cat for DFP formation in M (HЈ) ferritin (D140) is 4.3-fold higher, and the t 1/2 is 4.7-fold shorter than in H (S140) ferritin (Table 2 , Fig. 2 ). Cell-specific expression (41, 42) indicates a biological role for ferritin residue 140 isoforms, which may relate to rates of peroxide release (39) and signaling (44) .
The advantages of using ferritin chimeras, guest F ox sites in inactive hosts, are as follows: (i) direct identification of the active-site residues for DFP-mediated ferritin biomineralization, based on WT values of K app and the Hill coefficient (Table 2 and Fig. 4) ; (ii) illumination of a possible facile evolutionary path between diiron cofactor sites and diiron substrate sites in the diiron carboxylate family of proteins by comparison with DNA codons for each type of site; and (iii) demonstration, indirectly, of second-shell F ox site residues participating in substrate-product channeling that facilitate efficient catalysis. Future ferritin chimeras, designed to identify second-shell residues important in substrate-product channeling, will be based on the results of surface-potential analyses that showed a coincidence between charge distribution within 10 Å of the F ox site and differences in catalytic rates (unpublished data). Knowing the iron path in and out of the ferritin nanocavity, controlled by iron substrate-product channeling through the F ox site, is needed to understand ironoxygen chemistry in maxi-and miniferritins and to define ferritin targets for manipulating iron-oxygen chemistry in normal cells and pathogens bearing DNA production during starvation proteins. We thank Luming He, G. William Small, and A. Rene Tipton for site-directed mutagenesis and preliminary characterization of some of the chimeric ferritins, and Christina Yi for assistance in protein expression and purification. This work was supported in part by National Institutes of Health-National Institute of Diabetes and Digestive and Kidney Diseases Grant 20251.
